Nov 15, 2022

One forward, three back: Court Order Undermines Effectiveness of Zantac MDL

Posted by : ZeroRisk Cases Marketing

By Christina Grube (MASS TORT NEWS) U.S. District Judge Robin Rosenburg’s recent order reducing the number of cancers accepted under the Zantac MDL 2924 may serve to undermine the purpose and effectiveness of the MDL itself. In January, Judge Rosenburg reduced the number of cancers from 10 to 5, removing certain cancers (breast, prostate, colorectal, […]

The post One forward, three back: Court Order Undermines Effectiveness of Zantac MDL appeared first on Mass Tort News.

Be Sociable, Share!
author avatar
ZeroRisk Cases Marketing
We are a Client Acquisition Company, providing ZeroRisk Mass Tort Cases™ backed by our ZeroRisk Replacement Policy™. We use proprietary technology with our ZeroRisk Mass Tort Cases™ program to deliver high-value signed cases to obtain these cases. “We identify the highest quality, lowest cost, mass tort, and personal injury cases using medical diagnosis codes associated with the most valuable legal awards by purchasing aged account receivables and mining the data to retain qualified claimants.” The results: We provide the highest possible value to clients for each mass tort we can offer.